Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Natural Product Reports | journal | 3.285 Q1 | 211 | 82 | 218 | 15034 | 1973 | 209 | 9.13 | 183.34 | |
2 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.326 Q1 | 99 | 24 | 80 | 3831 | 424 | 75 | 5.23 | 159.63 | |
3 | Topics in Medicinal Chemistry | book series | 0.108 Q4 | 15 | 8 | 25 | 1218 | 2 | 19 | 0.08 | 152.25 | |
4 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.260 Q3 | 50 | 49 | 86 | 7199 | 57 | 78 | 0.60 | 146.92 | |
5 | Critical Reviews in Toxicology | journal | 1.939 Q1 | 129 | 36 | 125 | 5090 | 716 | 116 | 5.88 | 141.39 | |
6 | Progress in Medicinal Chemistry | journal | 0.962 Q2 | 38 | 6 | 28 | 836 | 61 | 17 | 1.75 | 139.33 | |
7 | Advanced Drug Delivery Reviews | journal | 4.880 Q1 | 366 | 114 | 406 | 14815 | 6169 | 359 | 11.76 | 129.96 | |
8 | Expert Opinion on Emerging Drugs | journal | 0.973 Q2 | 54 | 45 | 135 | 5658 | 526 | 135 | 3.97 | 125.73 | |
9 | Handbook of Experimental Pharmacology | journal | 1.759 Q1 | 110 | 131 | 364 | 14869 | 1764 | 337 | 5.33 | 113.50 | |
10 | Side Effects of Drugs Annual | book series | 0.106 Q4 | 9 | 52 | 157 | 5441 | 4 | 53 | 0.02 | 104.63 | |
11 | Advances in Molecular Toxicology | book series | 0.191 Q3 | 18 | 7 | 24 | 718 | 14 | 20 | 0.44 | 102.57 | |
12 | Issues in Toxicology | book series | 0.160 Q4 | 18 | 14 | 79 | 1436 | 39 | 74 | 0.44 | 102.57 | |
13 | Open Nanomedicine Journal | journal | 4 | 5 | 0 | 512 | 0 | 0 | 0.00 | 102.40 | ||
14 | Current Drug Metabolism | journal | 0.993 Q1 | 122 | 98 | 277 | 10022 | 1416 | 259 | 5.17 | 102.27 | |
15 | Expert Opinion on Drug Delivery | journal | 1.689 Q1 | 133 | 111 | 295 | 11234 | 1677 | 290 | 5.70 | 101.21 | |
16 | Expert Opinion on Therapeutic Targets | journal | 1.575 Q1 | 106 | 112 | 352 | 10954 | 1340 | 348 | 4.13 | 97.80 | |
17 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.389 Q3 | 30 | 26 | 79 | 2513 | 106 | 79 | 1.27 | 96.65 | |
18 | Expert Opinion on Drug Discovery | journal | 0.621 Q2 | 84 | 92 | 288 | 8715 | 571 | 283 | 2.24 | 94.73 | |
19 | Cellular and Molecular Life Sciences | journal | 4.190 Q1 | 261 | 297 | 912 | 27852 | 6861 | 900 | 6.90 | 93.78 | |
20 | Neurotherapeutics | journal | 2.457 Q1 | 136 | 68 | 193 | 6372 | 1459 | 180 | 6.63 | 93.71 | |
21 | Progress in Drug Research | book series | 0.760 Q1 | 46 | 15 | 20 | 1405 | 61 | 18 | 0.00 | 93.67 | |
22 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.018 Q1 | 100 | 120 | 369 | 11161 | 1500 | 365 | 3.53 | 93.01 | |
23 | Current Pharmaceutical Biotechnology | journal | 1.160 Q1 | 97 | 231 | 252 | 21146 | 909 | 230 | 3.16 | 91.54 | |
24 | Therapeutic Advances in Neurological Disorders | journal | 0.457 Q3 | 68 | 27 | 84 | 2375 | 149 | 76 | 1.98 | 87.96 | |
25 | Pharmaceuticals | journal | 0.431 Q2 | 87 | 89 | 208 | 7520 | 256 | 204 | 1.23 | 84.49 | |
26 | Expert Opinion on Biological Therapy | journal | 1.312 Q1 | 102 | 141 | 459 | 11869 | 1848 | 452 | 4.34 | 84.18 | |
27 | Expert Opinion on Therapeutic Patents | journal | 1.129 Q1 | 88 | 112 | 329 | 9333 | 991 | 320 | 3.86 | 83.33 | |
28 | CNS Neuroscience and Therapeutics | journal | 1.437 Q1 | 91 | 83 | 118 | 6890 | 558 | 110 | 4.46 | 83.01 | |
29 | Inflammation and Allergy - Drug Targets | journal | 0.972 Q2 | 55 | 59 | 129 | 4860 | 480 | 124 | 3.89 | 82.37 | |
30 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 47 | 4 | 0 | 327 | 0 | 0 | 0.00 | 81.75 | ||
31 | Trends in Pharmacological Sciences | journal | 5.422 Q1 | 244 | 90 | 249 | 6986 | 2845 | 232 | 11.29 | 77.62 | |
32 | Expert Opinion on Investigational Drugs | journal | 1.541 Q1 | 117 | 142 | 487 | 11009 | 2256 | 471 | 4.88 | 77.53 | |
33 | Expert Review of Clinical Pharmacology | journal | 0.297 Q2 | 60 | 69 | 197 | 5043 | 143 | 167 | 0.77 | 73.09 | |
34 | Expert Opinion on Pharmacotherapy | journal | 0.800 Q2 | 93 | 259 | 847 | 18824 | 2415 | 814 | 2.99 | 72.68 | |
35 | Expert Review of Vaccines | journal | 1.405 Q1 | 105 | 167 | 435 | 11738 | 1689 | 350 | 3.91 | 70.29 | |
36 | Neuropsychopharmacology | journal | 4.150 Q1 | 249 | 254 | 807 | 17601 | 6542 | 771 | 7.85 | 69.30 | |
37 | Cardiovascular Therapeutics | journal | 0.700 Q2 | 54 | 57 | 128 | 3887 | 288 | 115 | 2.19 | 68.19 | |
38 | Toxins | journal | 0.337 Q3 | 116 | 91 | 168 | 6200 | 187 | 167 | 1.11 | 68.13 | |
39 | Nano Today | journal | 6.990 Q1 | 175 | 65 | 132 | 4358 | 1527 | 102 | 11.19 | 67.05 | |
40 | Frontiers in Pharmacology | journal | 0.166 Q3 | 154 | 88 | 41 | 5841 | 32 | 41 | 0.78 | 66.38 | |
41 | Open Vaccine Journal | journal | 0.270 Q2 | 10 | 4 | 37 | 262 | 16 | 36 | 0.43 | 65.50 | |
42 | Pharmaceutics | journal | 0.274 Q2 | 106 | 49 | 30 | 3202 | 24 | 29 | 0.80 | 65.35 | |
43 | Neuropharmacology | journal | 2.293 Q1 | 191 | 323 | 771 | 20594 | 3973 | 758 | 5.18 | 63.76 | |
44 | Molecular Diagnosis and Therapy | journal | 0.759 Q2 | 68 | 32 | 115 | 2040 | 280 | 108 | 1.96 | 63.75 | |
45 | Future Medicinal Chemistry | journal | 0.845 Q2 | 90 | 166 | 260 | 10362 | 506 | 196 | 1.95 | 62.42 | |
46 | Therapeutic Delivery | journal | 0.206 Q3 | 63 | 143 | 70 | 8885 | 53 | 69 | 0.76 | 62.13 | |
47 | Journal of Drug Delivery Science and Technology | journal | 0.332 Q2 | 75 | 60 | 176 | 3711 | 153 | 174 | 0.82 | 61.85 | |
48 | Toxin Reviews | journal | 0.426 Q3 | 54 | 13 | 62 | 800 | 90 | 60 | 1.42 | 61.54 | |
49 | Journal of Psychopharmacology | journal | 1.194 Q1 | 135 | 166 | 501 | 10159 | 1617 | 451 | 3.18 | 61.20 | |
50 | Psychopharmacology | journal | 1.994 Q1 | 214 | 406 | 1000 | 24825 | 4635 | 966 | 4.30 | 61.15 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®